Insulin syringe By some estimates, the cost of insulin has tripled in the last ten years, even though the medication has stayed the same.

Public outrage over high insulin prices, fueled by stories of diabetes patients dying because they couldn’t afford their medication, is driving a new flurry of measures that aim to control or reduce prices for the drug.

It has been almost exactly two years since Jesse Lutgen died on Feb. 7, 2018, after losing his health insurance and not being able to afford insulin for his Type 1 diabetes. Lutgen’s death is one of more than ten similar cases in the last three years—Americans who died from a health condition that is easily treatable with medications that used to be more affordable.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.